Tcw Group Inc Biomarin Pharmaceutical Inc Transaction History

Tcw Group Inc

$11 Billion
Q2 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 23, 2021	SELL	$75.51 - $84.79 $1.12 Million - $1.26 Million	-14,882 Closed	0 $0
Q1 2021 May 05, 2021	SELL	$74.73 - $90.69 $50.2 Million - $60.9 Million	-671,133 Reduced 97.83%	14,882 $1.12 Million
Q4 2020 Feb 02, 2021	BUY	$72.61 - $90.2 $140,427 - $174,446	1,934 Added 0.28%	686,015 $60.2 Million
Q3 2020 Oct 30, 2020	SELL	$71.87 - $131.03 $978,941 - $1.78 Million	-13,621 Reduced 1.95%	684,081 $52 Million
Q2 2020 Aug 05, 2020	SELL	$79.55 - $124.22 $3.24 Million - $5.05 Million	-40,675 Reduced 5.51%	697,702 $86.1 Million
Q1 2020 May 05, 2020	SELL	$71.37 - $96.85 $176,069 - $238,928	-2,467 Reduced 0.33%	738,377 $62.4 Million
Q4 2019 Feb 10, 2020	SELL	$64.27 - $86.37 $2.06 Million - $2.77 Million	-32,064 Reduced 4.15%	740,844 $62.6 Million
Q3 2019 Nov 13, 2019	SELL	$67.4 - $85.11 $392,470 - $495,595	-5,823 Reduced 0.75%	772,908 $52.1 Million
Q2 2019 Aug 07, 2019	SELL	$80.35 - $93.9 $723,391 - $845,381	-9,003 Reduced 1.14%	778,731 $66.7 Million
Q1 2019 May 13, 2019	SELL	$84.2 - $98.62 $206,879 - $242,309	-2,457 Reduced 0.31%	787,734 $70 Million
Q4 2018 Feb 11, 2019	SELL	$80.14 - $106.07 $5.49 Million - $7.27 Million	-68,536 Reduced 7.98%	790,191 $67.3 Million
Q3 2018 Oct 30, 2018	SELL	$93.92 - $105.72 $373,425 - $420,342	-3,976 Reduced 0.46%	858,727 $83.3 Million
Q2 2018 Aug 02, 2018	SELL	$76.01 - $99.03 $3.52 Million - $4.58 Million	-46,268 Reduced 5.09%	862,703 $81.3 Million
Q1 2018 May 11, 2018	SELL	$77.67 - $92.63 $7.21 Million - $8.6 Million	-92,793 Reduced 9.26%	908,971 $73.7 Million
Q4 2017 Feb 09, 2018	SELL	$80.76 - $95.13 $5.75 Million - $6.77 Million	-71,205 Reduced 6.64%	1,001,764 $89.3 Million
Q3 2017 Nov 06, 2017	BUY	$80.6 - $94.95 $14.5 Million - $17.1 Million	179,879 Added 20.14%	1,072,969 $99.9 Million
Q2 2017 Aug 11, 2017	BUY	N/A	893,090	893,090 $81.1 Million

Others Institutions Holding BMRN

# of Institutions

632

Shares Held

185M

Call Options Held

1.63M

Put Options Held

1.2M

Black Rock Inc. New York, NY

22.7M
Shares

$1.6 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

19M
Shares

$1.34 Billion
0.03% of portfolio
Primecap Management CO Pasadena, CA

18.8M
Shares

$1.33 Billion
1.14% of portfolio
Dodge & Cox San Francisco, CA

13.9M
Shares

$983 Million
0.72% of portfolio
Capital Research Global Investors Los Angeles, CA

9.69M
Shares

$684 Million
0.18% of portfolio

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tcw Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Tcw Group Inc with notifications on news.

Account